Table 2.

Measured Extent of T-Cell Depletion In Vitro and Numbers of T Cells Infused

Ulm Royal Free Riyadh Study Group Historic Group
No. of patients measured  40  15  13  68  40 
Mononuclear cells (×108/kg)  1.4 (0.5-4.0) 0.5 (0.2-0.8)  0.1 (0.1-2.4)  1.0 (0.1-4.0) 2.2 (0.1-6.0)  
T cells (%)  0.8 (0.0-3.0) 0.2 (0.0-7.5)  0.2 (0.0-2.7)  0.4 (0.0-7.5) 1.0 (0.0-10.0)  
T cells infused (×106/kg) 0.8 (0.0-5.4)  0.12 (0.0-3.7)  0.04 (0.0-2.2) 0.2 (0.0-5.4)  1.7 (0.0-25.0) 
Ulm Royal Free Riyadh Study Group Historic Group
No. of patients measured  40  15  13  68  40 
Mononuclear cells (×108/kg)  1.4 (0.5-4.0) 0.5 (0.2-0.8)  0.1 (0.1-2.4)  1.0 (0.1-4.0) 2.2 (0.1-6.0)  
T cells (%)  0.8 (0.0-3.0) 0.2 (0.0-7.5)  0.2 (0.0-2.7)  0.4 (0.0-7.5) 1.0 (0.0-10.0)  
T cells infused (×106/kg) 0.8 (0.0-5.4)  0.12 (0.0-3.7)  0.04 (0.0-2.2) 0.2 (0.0-5.4)  1.7 (0.0-25.0) 

Cell numbers are reported as medians, with the range in parentheses. There was a statistically significant difference between each study center in the total numbers of mononuclear cells (P < .005), but there was no significant difference between centers in the percentage of residual T cells or the total numbers of T cells infused. However, there was a significant difference between the study group and the historic control group with regard to each of these parameters (P = .024 for percentage of T cells and P < .001 for total T cells).

Close Modal

or Create an Account

Close Modal
Close Modal